⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole SCHEMBL29178177 | 1.00 | — | — | |
| Imidazole SCHEMBL28744226 | 0.93 | ALDH1A1 (1.00) | — | |
| Imidazole SCHEMBL1331382 | 0.93 | — | — | |
| Imidazole SCHEMBL19028065 | 0.93 | ALDH1A1 (1.00) | — | |
| Imidazole SCHEMBL2684565 | 0.93 | ALDH1A1 (1.00) | — | |
| Imidazole SCHEMBL30382963 | 0.93 | — | — | |
| Imidazole SCHEMBL897 | 0.93 | — | — | |
| Imidazole SCHEMBL1331920 | 0.93 | — | — | |
| Imidazole SCHEMBL2635292 | 0.93 | — | — | |
| Imidazole SCHEMBL8509368 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107466212-A | Use the oligosaccharide composition of animal feed and its manufacture method | 卡德纳生物股份有限公司 | 2017-12-12 | — | — | CN | disclosed |
| CN-107428789-A | Oligosaccharide composition for nutritional composition and method for producing the same | 卡德纳生物股份有限公司 | 2017-12-01 | — | — | CN | disclosed |
| CN-107427042-A | Oligosaccharide composition used as food ingredient and its preparation method | 卡德纳生物股份有限公司 | 2017-12-01 | — | — | CN | disclosed |
| US-20160257957-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-09-08 | — | — | US | disclosed |
| EP-2544688-B1 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME | HARVARD COLLEGE (US) | 2016-09-07 | — | — | EP | disclosed |
| CN-102191233-B | Novel 10-23 deoxyribozyme analogue and application thereof | INST PHARM & TOXICOLOGY AMMS | 2014-06-04 | — | — | CN | disclosed |
| US-20130058915-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | Children's Medica Center Corporation (US) | 2013-03-07 | — | — | US | disclosed |
| EP-2544688-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | President and Fellows of Harvard College (US) | 2013-01-16 | — | — | EP | disclosed |
| CN-102191233-A | Novel 10-23 deoxyribozyme analogue and application thereof | INST PHARM & TOXICOLOGY AMMS | 2011-09-21 | — | — | CN | disclosed |
| WO-2011109398-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-09-09 | — | — | WO | disclosed |
| US-20110123877-A1 | CATALYST FOR OXYGEN REDUCTION ELECTRODE AND OXYGEN REDUCTION ELECTRODE | NEC CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |